WO1994020151A1 - Verfahren zum herstellen eines implantates aus zellkulturen - Google Patents
Verfahren zum herstellen eines implantates aus zellkulturen Download PDFInfo
- Publication number
- WO1994020151A1 WO1994020151A1 PCT/DE1994/000235 DE9400235W WO9420151A1 WO 1994020151 A1 WO1994020151 A1 WO 1994020151A1 DE 9400235 W DE9400235 W DE 9400235W WO 9420151 A1 WO9420151 A1 WO 9420151A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cells
- support structure
- carrier structure
- implant
- nutrient solution
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
- A61L27/3843—Connective tissue
- A61L27/3852—Cartilage, e.g. meniscus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3817—Cartilage-forming cells, e.g. pre-chondrocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
- C12N5/0075—General culture methods using substrates using microcarriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30756—Cartilage endoprostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/3006—Properties of materials and coating materials
- A61F2002/30062—(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30108—Shapes
- A61F2002/30199—Three-dimensional shapes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30108—Shapes
- A61F2002/30199—Three-dimensional shapes
- A61F2002/30242—Three-dimensional shapes spherical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0071—Three-dimensional shapes spherical
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
- C12N2533/40—Polyhydroxyacids, e.g. polymers of glycolic or lactic acid (PGA, PLA, PLGA); Bioresorbable polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/70—Polysaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/70—Polysaccharides
- C12N2533/76—Agarose, agar-agar
Definitions
- the invention relates to a method for producing an implant from cell cultures, in particular an implant with cartilage cells, these cells being applied to a resorbable carrier structure and then being implanted.
- the required tissue can be removed from corpses, preserved and then implanted. In some cases, immune reactions occur.
- the patient's own tissue can be used, which is removed from the patient at a different location that is not visible from the outside and implanted at the location of the removed tissue. No immune reactions are to be feared here.
- a third method has therefore been proposed, namely cells which have been isolated and propagated in a conventional manner on a polymer fiber bundle made of resorbable material apply and implant the bundles; see. CAVacanti et al. , Plastic and Reconstructive Surgery, Vol. 8, No. 5, Nov. 1991, pp. 753-759.
- the implant By stacking the bundles on top of and next to each other, the implant could be modeled three-dimensionally.
- the polymer material is resorbed, and at the same time the intercellular matrix, in particular collagen, is to be built up between the individual cells, so that in the final stage, a fully functional tissue structure is integrated into the surrounding tissue.
- Difficulties with this method should arise when modeling the desired implant, since the shape of the fiber bundles placed one above the other and next to one another is not to be expected during the resorption of the fiber material. In addition, larger implants would have difficulty feeding the individual cells located inside the implant.
- the invention is based on the object of specifying a method with which cell tissue, in particular cartilage tissue, is made available in a configuration which is favorable for implantation.
- the implant should have good formability and shape retention in the implanted state and ensure the nutrition of the individual cells in the implant.
- the basic idea of the invention is accordingly a three-dimensional, stable support structure with the desired implant shape made of a material with a coherent inner surface and a small one Volume, for example a polymer fleece, to introduce cells into the inner cavity of the carrier structure and to flow through the carrier structure receiving the cells with a nutrient solution. As soon as the intercellular matrix has at least partially formed, the entire three-dimensional support structure can be implanted.
- the three-dimensional support structure ensures that the cells with their intercellular matrix remain dimensionally stable even during absorption and that the desired shape of the implant is maintained even after the implantation.
- Perfusion ensures that the cells located within the support structure are also adequately supplied with nutrient solution and that this supply is maintained when the intercellular matrix has at least partially built up.
- the nutrient solution enters the support structure and penetrates it essentially only by diffusion, which also corresponds to the situation in vivo.
- the nourishment of the cells accommodated in the carrier structure by diffusion can also be ensured by coating the entire carrier structure with a material that essentially only allows diffusion. Such a material is e.g. Agarose.
- the patient's own cartilage cells are grown in a conventional manner on a culture medium.
- a carrier structure is produced from a resorbable, dimensionally stable polymer fiber fleece, the shape of which corresponds to the later implant.
- Suitable nonwoven materials are e.g. Polyglycols or polylactides. From this, nonwovens can be produced that have a large inner coherent surface with a minimal material volume.
- the continuous inner surface of the support structure is covered with an adhesion factor, e.g. Poly-L-lysine coated or wetted. This wetting takes place e.g. by immersing the support structure in a polylysine solution and subsequent lyophilization, i.e. Freeze drying so that the adhesion factor covers essentially the entire inner surface of the support structure.
- a resorbable, viscosity-increasing substance for example the agarose mentioned, can be added.
- the carrier structure receiving the cell is then coated with agarose, e.g. the support structure is immersed in a 2% agarose solution.
- the support structure is then subjected to a cold shock, e.g. by immersion in a cold water bath at about 4 ° C., whereby the agarose of the jacket and also the agarose, if any, added to the suspension solidify.
- a cold shock e.g. by immersion in a cold water bath at about 4 ° C.
- This carrier structure prepared in this way is designated 1 in the figure and is inserted into a perfusion apparatus 2.
- This apparatus 2 consists of a housing 3, in which a perfusion chamber 4 is provided, into which the carrier structure is inserted.
- a feed line 5 for a nutrient solution opens into the housing 3 and initially enters a mixing chamber 6, in which the flow is evened out before it enters the perfusion chamber 4.
- An outflow chamber 7 then adjoins the perfusion chamber 4, from which an outflow line 8 leads to a collecting container 9.
- the housing 3 of the perfusion chamber 4 is covered with a cover 10 and is kept at a constant temperature corresponding to the mean body temperature of 37 ° C. by a heater 11.
- the actual perfusion chamber 4 can still be at least partially filled with agarose.
- a nutrient solution for example the solution commercially available under the name Hams F12, is slowly passed through the perfusion chamber 4.
- This nutrient solution is transported by a pump 12, for example a peristaltic pump, which is arranged in the feed line 5 and nutrient solution from one Sucks reservoir 13.
- This reservoir 13 is located, for example, in a water bath 14 at a temperature of 4 ° C.
- the amount of time that the peristaltic pump 12 is transported is very small and, in the present case, is set at approximately one milliliter per hour for the production of cartilage tissue.
- Some support structures - three such support structures 1 in the perfusion chamber 4 are shown in the drawing - can thus be sufficiently nourished, these support structures having a cross-section of at most one thumb nail size.
- the peristaltic pump 12 is controlled at intervals by a timer 15, the intervals being adjustable depending on the size of the support structures and the perfusion chamber: in practice, the pumping and pausing intervals will be in the minute or hour range. Good results were achieved at pump and break intervals of approx. 30 minutes each.
- Perfusion devices are known per se. They are otherwise used to grow cell cultures that are attached to a membrane with continuous conditions, thus replacing the conventional petri dishes. The membranes with the applied cell cultures can be inserted through slots into the perfusion chamber.
- the nutrient solution passed through the perfusion apparatus 2 diffuses through the agarose jacket into the carrier structure 1, so that the cells taken up therein are fed.
- the flow of the nutrient solution and the interval control are set so that the cell products necessary for the construction of the intercellular matrix are not washed away, but remain in place. Over time, the intercellular matrix with its collagen fibers forms between the cells, so that the cells are bound together.
- the support structure and the agarose can at least partially dissolve during this long process. Due to the formation of the intercellular matrix, however, the predetermined shape and thus also the desired shape of the later implant is retained.
- the support structure is removed from the perfusion chamber and implanted. Over time, the matrix continues to develop as the support structure is reabsorbed.
- tissue orphogenic factors to the fleece of the support structure.
- Such morphogenic factors stimulate cell formation and the formation of the intercellular matrix and thus cartilage formation.
- Such factors can either be introduced into the support structure during the formation of the intercellular matrix in the perfusion chamber or after the implantation into the support structure.
- An elegant solution is to couple the tissue-morphogenic factor directly to the nonwoven material or to an antibody and to provide the nonwoven material of the carrier structure with haptens to which the antibodies attach. As a result, these factors only act locally in the area of the support structure.
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP94908950A EP0687185A1 (de) | 1993-03-03 | 1994-03-03 | Verfahren zum herstellen eines implantates aus zellkulturen |
JP51945594A JP3567268B2 (ja) | 1993-03-03 | 1994-03-03 | 細胞培養から移植体を作成する方法 |
US08/513,995 US5891455A (en) | 1993-03-03 | 1994-03-03 | Process for producing an implant from cell cultures |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4306661A DE4306661C2 (de) | 1993-03-03 | 1993-03-03 | Verfahren zum Herstellen eines Implantates aus Zellkulturen |
DEP4306661.5 | 1993-03-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1994020151A1 true WO1994020151A1 (de) | 1994-09-15 |
Family
ID=6481857
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE1994/000235 WO1994020151A1 (de) | 1993-03-03 | 1994-03-03 | Verfahren zum herstellen eines implantates aus zellkulturen |
Country Status (5)
Country | Link |
---|---|
US (1) | US5891455A (de) |
EP (1) | EP0687185A1 (de) |
JP (1) | JP3567268B2 (de) |
DE (1) | DE4306661C2 (de) |
WO (1) | WO1994020151A1 (de) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19505070A1 (de) * | 1995-02-15 | 1996-08-22 | Axel Prof Dr Med Haverich | Künstliche Gefäßsysteme |
DE19648876A1 (de) * | 1996-11-16 | 1998-05-28 | Will Prof Dr Minuth | Verfahren zum Herstellen eines natürlichen Implantats |
EP0934750A3 (de) * | 1998-01-30 | 2000-07-12 | Meenen, Norbert PD Dr. | Biohybrider Gelenkflächenersatz |
US6187053B1 (en) | 1996-11-16 | 2001-02-13 | Will Minuth | Process for producing a natural implant |
DE19959088A1 (de) * | 1999-12-08 | 2001-06-13 | Inst Textil & Faserforschung | Medizintechnisches Produkt, Verfahren zu seiner Herstellung und Verwendung |
US6569172B2 (en) | 1996-08-30 | 2003-05-27 | Verigen Transplantation Service International (Vtsi) | Method, instruments, and kit for autologous transplantation |
US6592599B2 (en) | 1996-08-30 | 2003-07-15 | Verigen Transplantation Service International (Vtsi) | Method, instruments, and kit for autologous transplantation |
WO2007020713A1 (ja) | 2005-08-18 | 2007-02-22 | Koken Co., Ltd. | 生体内に埋設可能な細胞培養担体 |
US7445793B2 (en) | 2002-09-09 | 2008-11-04 | Kaneka Corporation | Support for tissue regeneration and process for producing the same |
USRE41286E1 (en) | 1997-08-14 | 2010-04-27 | Zimmer Orthobiologics, Inc. | Compositions for regeneration and repair of cartilage lesions |
US8945535B2 (en) | 2005-09-20 | 2015-02-03 | Zimmer Orthobiologics, Inc. | Implant for the repair of a cartilage defect and method for manufacturing the implant |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4431598C2 (de) * | 1993-03-03 | 1997-03-20 | Michael Sittinger | Verfahren zum Herstellen eines Implantates aus Zellkulturen |
WO1997015655A2 (de) * | 1995-10-20 | 1997-05-01 | Michael Sittinger | Neue künstliche gewebe, verfahren zu ihrer herstellung und ihre verwendung |
DE59710789D1 (de) | 1996-06-04 | 2003-10-30 | Sulzer Orthopedics Ltd | Verfahren zur herstellung von knorpelgewebe und von implantaten |
US20060025786A1 (en) * | 1996-08-30 | 2006-02-02 | Verigen Transplantation Service International (Vtsi) Ag | Method for autologous transplantation |
US20020173806A1 (en) * | 1996-08-30 | 2002-11-21 | Verigen Transplantation Service International (Vtsi) Ag | Method for autologous transplantation |
US6171610B1 (en) | 1998-04-24 | 2001-01-09 | University Of Massachusetts | Guided development and support of hydrogel-cell compositions |
US20020116063A1 (en) * | 1999-08-02 | 2002-08-22 | Bruno Giannetti | Kit for chondrocyte cell transplantation |
US20030096411A1 (en) * | 1999-12-07 | 2003-05-22 | George Michalopoulos | Novel long-term three-dimensional tissue culture system |
US6737270B1 (en) | 1999-12-07 | 2004-05-18 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Long-term three dimensional tissue culture system |
JP3865354B2 (ja) | 2000-03-02 | 2007-01-10 | 高木産業株式会社 | 細胞又は組織の培養方法 |
US20030060695A1 (en) * | 2001-03-07 | 2003-03-27 | Connelly Patrick R. | Implantable artificial organ devices |
US7252982B2 (en) | 2001-03-15 | 2007-08-07 | Massachusetts Institute Of Technology | Tissue engineering enhanced by the transfer of a growth factor gene |
WO2003087292A2 (en) | 2002-04-08 | 2003-10-23 | Millenium Biologix Inc. | Automated tissue engineering system |
CN1309428C (zh) * | 2002-05-13 | 2007-04-11 | 东芝陶瓷株式会社 | 关节软骨再生材料及其制造方法、关节软骨的再生方法及培养方法以及移植用人造关节软骨 |
US7622562B2 (en) | 2002-06-26 | 2009-11-24 | Zimmer Orthobiologics, Inc. | Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue |
US20040136968A1 (en) * | 2002-09-27 | 2004-07-15 | Verigen Ag | Autologous cells on a support matrix for tissue repair |
US20040151729A1 (en) * | 2002-10-28 | 2004-08-05 | George Michalopoulos | Novel long-term three-dimensional culture system |
DE10333901A1 (de) * | 2003-07-21 | 2005-03-10 | Transtissue Technologies Gmbh | Verwendung von Chemokinen zur Rekrutierung von humanen mesenchymalen Vorläuferzellen zur Regeneration von Gelenkdefekten |
DE10349484A1 (de) * | 2003-10-21 | 2005-05-25 | Universität Leipzig | Verfahren und Bioreaktor zum Kultivieren und Stimulieren von dreidimensionalen, vitalen und mechanisch widerstandsfähigen Zelltransplantaten |
ES2403357T3 (es) * | 2003-12-11 | 2013-05-17 | Isto Technologies Inc. | Sistema de cartílago particulado |
US8512730B2 (en) | 2004-07-12 | 2013-08-20 | Isto Technologies, Inc. | Methods of tissue repair and compositions therefor |
DE102005021509A1 (de) * | 2005-05-04 | 2006-11-09 | Matthias Schreiber | Gewebekultursystem zur Gewinnung von Gefäßen, Gefäßverbänden und Hohlorganen in einer Schichtlage durch externe Formung in Kulturformen und Grundaufbau, der für die Kultur verwendeten Kulturformen und Kulturnadeln |
DE102005030614B4 (de) | 2005-06-30 | 2014-05-08 | Biotissue Ag | Zellfreies Transplantat, dessen Verwendung, Verfahren zu dessen Herstellung, dabei hergestellte Matrix mit Gel und Verfahren zur Herstellung dieser Matrix mit Gel |
AU2006282754A1 (en) | 2005-08-26 | 2007-03-01 | Zimmer, Inc. | Implants and methods for repair, replacement and treatment of joint disease |
DE102006047346A1 (de) | 2006-10-06 | 2008-04-10 | Transtissue Technologies Gmbh | Matrix-Gel-Transplantat ohne Zellen |
US8163549B2 (en) | 2006-12-20 | 2012-04-24 | Zimmer Orthobiologics, Inc. | Method of obtaining viable small tissue particles and use for tissue repair |
CA2684040C (en) | 2007-04-12 | 2016-12-06 | Isto Technologies, Inc. | Method of forming an implant using a mold that mimics the shape of the tissue defect site and implant formed therefrom |
AT506826B1 (de) * | 2008-05-23 | 2010-03-15 | Greiner Bio One Gmbh | Bioreaktor und verfahren zum kultivieren von zellen und geweben |
KR20100056718A (ko) * | 2008-11-20 | 2010-05-28 | 한국과학기술연구원 | 형상회복력을 갖는 고탄성 생분해성 고분자 지지체 및 이를이용한 관절 연골 손상의 치료 |
WO2011060135A1 (en) | 2009-11-12 | 2011-05-19 | Vbi Technologies, Llc | Subpopulations of spore-like cells and uses thereof |
US10245306B2 (en) | 2012-11-16 | 2019-04-02 | Isto Technologies Ii, Llc | Flexible tissue matrix and methods for joint repair |
US20140178343A1 (en) | 2012-12-21 | 2014-06-26 | Jian Q. Yao | Supports and methods for promoting integration of cartilage tissue explants |
US10179191B2 (en) | 2014-10-09 | 2019-01-15 | Isto Technologies Ii, Llc | Flexible tissue matrix and methods for joint repair |
KR102296580B1 (ko) | 2017-09-01 | 2021-09-02 | 론자 워커스빌 아이엔씨. | 엔드-투-엔드 세포 요법의 자동화 |
US11718833B2 (en) | 2018-12-21 | 2023-08-08 | Lonza Walkersville, Inc. | Automated production of viral vectors |
WO2020124231A1 (en) | 2018-12-21 | 2020-06-25 | Octane Biotech Inc. | Carousel for modular biologic production units |
JP2022516476A (ja) | 2018-12-28 | 2022-02-28 | オクタン バイオテック インコーポレーテッド | 制御された環境ゾーンを有する細胞培養および組織工学システム |
US11773365B2 (en) | 2019-02-08 | 2023-10-03 | Lonza Walkersville, Inc. | Cell concentration methods and devices for use in automated bioreactors |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1985004185A1 (en) * | 1984-03-20 | 1985-09-26 | Caplan Arnold I | Process of and material for stimulating growth of cartilage and bony tissue at anatomical sites |
WO1988003785A1 (en) * | 1986-11-20 | 1988-06-02 | Vacanti Joseph P | Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices |
EP0282746A1 (de) * | 1987-02-19 | 1988-09-21 | Takeda Chemical Industries, Ltd. | Methode zur Herstellung von künstlichem Gewebe |
US4846835A (en) * | 1987-06-15 | 1989-07-11 | Grande Daniel A | Technique for healing lesions in cartilage |
WO1990012603A1 (en) * | 1989-04-17 | 1990-11-01 | Vacanti Joseph P | Neomorphogenesis of cartilage in vivo from cell culture |
EP0470681A2 (de) * | 1990-08-08 | 1992-02-12 | W.R. Grace & Co.-Conn. | Zellmassen oder Zellschichten mit einer Mehrheit von Zellarten und ihre Herstellung |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991001720A1 (en) * | 1989-08-07 | 1991-02-21 | Herman Wade Schlameus | Composition and method of promoting hard tissue healing |
-
1993
- 1993-03-03 DE DE4306661A patent/DE4306661C2/de not_active Expired - Lifetime
-
1994
- 1994-03-03 WO PCT/DE1994/000235 patent/WO1994020151A1/de not_active Application Discontinuation
- 1994-03-03 US US08/513,995 patent/US5891455A/en not_active Expired - Fee Related
- 1994-03-03 EP EP94908950A patent/EP0687185A1/de not_active Withdrawn
- 1994-03-03 JP JP51945594A patent/JP3567268B2/ja not_active Expired - Lifetime
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1985004185A1 (en) * | 1984-03-20 | 1985-09-26 | Caplan Arnold I | Process of and material for stimulating growth of cartilage and bony tissue at anatomical sites |
WO1988003785A1 (en) * | 1986-11-20 | 1988-06-02 | Vacanti Joseph P | Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices |
EP0282746A1 (de) * | 1987-02-19 | 1988-09-21 | Takeda Chemical Industries, Ltd. | Methode zur Herstellung von künstlichem Gewebe |
US4846835A (en) * | 1987-06-15 | 1989-07-11 | Grande Daniel A | Technique for healing lesions in cartilage |
WO1990012603A1 (en) * | 1989-04-17 | 1990-11-01 | Vacanti Joseph P | Neomorphogenesis of cartilage in vivo from cell culture |
EP0470681A2 (de) * | 1990-08-08 | 1992-02-12 | W.R. Grace & Co.-Conn. | Zellmassen oder Zellschichten mit einer Mehrheit von Zellarten und ihre Herstellung |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19505070A1 (de) * | 1995-02-15 | 1996-08-22 | Axel Prof Dr Med Haverich | Künstliche Gefäßsysteme |
US7048750B2 (en) | 1996-08-30 | 2006-05-23 | Verigen Ag | Method, instruments, and kits for autologous transplantation |
US6592598B2 (en) | 1996-08-30 | 2003-07-15 | Verigen Transplantation Service International (Vtsi) | Method, instruments, and kit for autologous transplantation |
US6599300B2 (en) | 1996-08-30 | 2003-07-29 | Verigen Transplantation Service International (Vtsi) | Method, instruments, and kit for autologous transplantation |
US6569172B2 (en) | 1996-08-30 | 2003-05-27 | Verigen Transplantation Service International (Vtsi) | Method, instruments, and kit for autologous transplantation |
US6599301B2 (en) | 1996-08-30 | 2003-07-29 | Verrgen Transplantation Service International (Vtsi) | Method, instruments, and kit for autologous transplantation |
US6592599B2 (en) | 1996-08-30 | 2003-07-15 | Verigen Transplantation Service International (Vtsi) | Method, instruments, and kit for autologous transplantation |
US7137989B2 (en) | 1996-08-30 | 2006-11-21 | Verigen Ag | Method, instruments, and kit for autologous transplantation |
US6187053B1 (en) | 1996-11-16 | 2001-02-13 | Will Minuth | Process for producing a natural implant |
DE19648876C2 (de) * | 1996-11-16 | 1999-10-07 | Will Minuth | Verfahren zum Herstellen eines natürlichen Implantats |
DE19648876A1 (de) * | 1996-11-16 | 1998-05-28 | Will Prof Dr Minuth | Verfahren zum Herstellen eines natürlichen Implantats |
USRE41286E1 (en) | 1997-08-14 | 2010-04-27 | Zimmer Orthobiologics, Inc. | Compositions for regeneration and repair of cartilage lesions |
US6319712B1 (en) | 1998-01-30 | 2001-11-20 | Deutsche Institute Fur Textil-Und Faserforschung Stuttgart | Biohybrid articular surface replacement |
EP0934750A3 (de) * | 1998-01-30 | 2000-07-12 | Meenen, Norbert PD Dr. | Biohybrider Gelenkflächenersatz |
DE19959088A1 (de) * | 1999-12-08 | 2001-06-13 | Inst Textil & Faserforschung | Medizintechnisches Produkt, Verfahren zu seiner Herstellung und Verwendung |
US7445793B2 (en) | 2002-09-09 | 2008-11-04 | Kaneka Corporation | Support for tissue regeneration and process for producing the same |
WO2007020713A1 (ja) | 2005-08-18 | 2007-02-22 | Koken Co., Ltd. | 生体内に埋設可能な細胞培養担体 |
US8945535B2 (en) | 2005-09-20 | 2015-02-03 | Zimmer Orthobiologics, Inc. | Implant for the repair of a cartilage defect and method for manufacturing the implant |
Also Published As
Publication number | Publication date |
---|---|
DE4306661A1 (de) | 1994-09-08 |
EP0687185A1 (de) | 1995-12-20 |
US5891455A (en) | 1999-04-06 |
JPH08511679A (ja) | 1996-12-10 |
JP3567268B2 (ja) | 2004-09-22 |
DE4306661C2 (de) | 1995-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE4306661C2 (de) | Verfahren zum Herstellen eines Implantates aus Zellkulturen | |
DE69535324T2 (de) | Mediumdurchdringender Zellkulturträger und seine Verwendungen in eine Kulturmethode und einem Apparat | |
DE69432865T2 (de) | Implantierbare prothese, kit und vorrichtung zu deren herstellung | |
DE10021627B4 (de) | Verfahren zur Herstellung eines vaskularisierten bioartifiziellen Gewebes und zugehöriger Versuchsreaktor | |
DE2726313C3 (de) | Verfahren zur in-vitro-Biosynthese von Hormonen, insbesondere von Insulin | |
DE69531821T2 (de) | Mehrlagige alginatbeschichtungen von biologischen geweben für die transplantation | |
DE60003006T2 (de) | Mineralisierung und zelluläre strukturierung von biomaterialoberflächen | |
EP1457552B1 (de) | Trägermaterial für die Gewebe- und Zellkultur, zur Herstellung von Implantaten oder Implantatmaterialien, und ein mit dem Trägermaterial hergestelltes Implantat | |
DE60133432T2 (de) | Biomaterial | |
DE60213432T2 (de) | Verfahren und anlyse zur züchtung von organischen gewebekulturen | |
WO1997015655A2 (de) | Neue künstliche gewebe, verfahren zu ihrer herstellung und ihre verwendung | |
CH657786A5 (de) | Verfahren zum einkapseln eines kernmaterials innerhalb einer semipermeablen membran. | |
WO2005040332A2 (de) | Verfahren und bioreaktor zum kultivieren und stimulieren von dreidimensionalen, vitalen und mechanisch widerstandsfähigen zelltransplantaten | |
EP2288688A2 (de) | Perfundierbarer bioreaktor zur herstellung von menschlichen oder tierischen geweben | |
EP2569141B1 (de) | Verfahren zur herstellung einer organnachbildung, insbesondere eines funktionsmodells | |
AT506826B1 (de) | Bioreaktor und verfahren zum kultivieren von zellen und geweben | |
DE19529036A1 (de) | Biokompatibler Verbundwerkstoff und Verfahren zu seiner Herstellung | |
WO1986000293A1 (en) | Method and plant for continuously producing biological humus-forming fertilizer | |
DE60120127T2 (de) | Injizierbare mikrokügelchen für den gewebeaufbau | |
WO2021023708A1 (de) | Verfahren zum 3d druck von vaskularisierten geweben und organen | |
DE19648876C2 (de) | Verfahren zum Herstellen eines natürlichen Implantats | |
DE19540487A1 (de) | Zellinteraktionssystem zur Induktion künstlicher Gewebe | |
EP1287118B1 (de) | Verfahren zur herstellung eines empfängerspezifischen gewebe-transplantats oder -implantats | |
EP1362092B1 (de) | Verfahren zur herstellung eines biologischen gewebes unter verwendung einer kollagenunterlage und zugehöriges gewebekonstrukt | |
DE19906172C1 (de) | Resorbierbares Implantat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1994908950 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1994908950 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 08513995 Country of ref document: US |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1994908950 Country of ref document: EP |